TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Abbott Shares Higher on Fourth-Quarter Results
Play
INVESTING

PhaseBio Cleared by FDA for Trial of Virus Treatment

  • By Tony Owusu
  • May 28, 2020 10:00 AM EDT
PRESS RELEASES

PhaseBio Provides Pemziviptadil (PB1046) Program Update

  • By Business Wire
  • Oct 23, 2020 8:00 AM EDT
PRESS RELEASES

PhaseBio To Present At The H.C. Wainwright 22nd Annual Global Investment Conference

  • By Business Wire
  • Sep 9, 2020 4:05 PM EDT
PRESS RELEASES

PhaseBio To Present At The William Blair Biotech Focus Conference 2020

  • By Business Wire
  • Aug 3, 2020 4:01 PM EDT
PRESS RELEASES

PhaseBio Doses First Patient In VANGARD Phase 2 Clinical Trial To Evaluate PB1046 For Hospitalized COVID-19 Patients

  • By Business Wire
  • Jul 16, 2020 4:05 PM EDT
Abbott Shares Higher on Fourth-Quarter Results
INVESTING

PhaseBio Cleared by FDA for Trial of Virus Treatment

  • By Tony Owusu
  • May 28, 2020 10:00 AM EDT
PRESS RELEASES

PhaseBio Launches Clinical Trial To Evaluate PB1046 As A Treatment For Hospitalized COVID-19 Patients

  • By Business Wire
  • May 27, 2020 4:01 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.